Cargando…
Different effects of oxycodone and remifentanil in patients undergoing ultrasound-guided percutaneous radiofrequency ablation of hepatic cancer: a randomized trial
BACKGROUND: Percutaneous radiofrequency ablation (RFA) is a recently introduced alternative technique for the treatment of hepatic cancer. Anesthesia is required for RFA of hepatic cancer to achieve patient comfort and immobilization during this painful procedure. The purpose of this study was to in...
Autores principales: | Wu, Junbei, Lu, Yunhong, Cao, Xiaofei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6342212/ https://www.ncbi.nlm.nih.gov/pubmed/30705584 http://dx.doi.org/10.2147/DDDT.S188728 |
Ejemplares similares
-
Sedation and Analgesia for Liver Cancer Percutaneous Radiofrequency Ablation: Fentanyl and Oxycodone Comparison
por: Wang, Jiangling, et al.
Publicado: (2020) -
Software-based planning of ultrasound and CT-guided percutaneous radiofrequency ablation in hepatic tumors
por: van Amerongen, M. J., et al.
Publicado: (2021) -
Combined Transarterial Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma Infeasible for Ultrasound-Guided Percutaneous Radiofrequency Ablation: A Comparative Study with General Ultrasound-Guided Radiofrequency Ablation Outcomes
por: Cha, Dong Ik, et al.
Publicado: (2023) -
Long-term survival of hepatocellular carcinoma after percutaneous radiofrequency ablation guided by ultrasound
por: Zhang, Weimin, et al.
Publicado: (2017) -
Percutaneous ultrasound guided PEG-coated gold nanoparticles enhanced radiofrequency ablation in liver
por: Mocan, Tudor, et al.
Publicado: (2021)